Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer—Implications for Pathogenesis and Therapy
Several studies show that triple-negative breast cancer (TNBC) patients have the lowest vitamin D concentration among all breast cancer types, suggesting that this vitamin may induce a protective effect against TNBC. This effect of the active metabolite of vitamin D, 1α,25-dihydroxyvitamin D3 (1,25(...
Main Authors: | Janusz Blasiak, Elzbieta Pawlowska, Jan Chojnacki, Joanna Szczepanska, Michal Fila, Cezary Chojnacki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/10/3670 |
Similar Items
-
Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis
by: Haixia Chen, et al.
Published: (2018-08-01) -
The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
by: Olga Caramelo, et al.
Published: (2019-03-01) -
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
by: Christoph Engel, et al.
Published: (2018-03-01) -
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
by: Wijden Mahfoudh, et al.
Published: (2019-04-01) -
Interplay between BRCA1 and GADD45A and Its Potential for Nucleotide Excision Repair in Breast Cancer Pathogenesis
by: Sylwia Pietrasik, et al.
Published: (2020-01-01)